High Quality for Acetaminophen - Pregabalin CAS 148553-50-8 Purity ≥99.0% (HPLC) Antiepileptic API – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

From the past few years, our firm absorbed and digested sophisticated technologies equally at home and abroad. Meanwhile, our organization staffs a group of experts devoted into the growth of Molecular Formula C7H4BrNO3, Molecular Formula C9H13N3O5, Weight 266.25, If you pursuit the Hi-quality, Hi-stable, Competitive price parts, company name is your best choice!

High Quality for Acetaminophen - Pregabalin CAS 148553-50-8 Purity ≥99.0% (HPLC) Antiepileptic API – Ruifu Detail:

Manufacturer with High Purity and Stable Quality
Chemical Name: Pregabalin
CAS: 148553-50-8
Pregabalin is a second-generation antiepileptic drug (AED)
API High Quality, Commercial Production

Chemical Name	Pregabalin
CAS Number	148553-50-8
CAT Number	RF-API57
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C8H17NO2
Molecular Weight	159.23
Brand	Ruifu Chemical

Item	Specifications
Appearance	White to Off-White Powder
Identification	A. Meets the Requirement B. IR: Similar to Reference Substance
Loss on Drying	≤0.50%
Specific Rotation	+10.0°~+13.0°
Related Substances
Any Single Impurity	≤0.10%
Total Impurities	≤0.80%
Purity By HPLC R-Isomer	≤0.15%
Residue on Ignition	≤0.10%
Residual Solvents
Isopropyl Alcohol	≤5000ppm
Ethyl Acetate	≤5000ppm
Heavy Metals	≤10ppm
Chlorides	≤0.05%
Assay	98.0%~102.0%
Test Standard	Enterprise Standard
Usage	Active Pharmaceutical Ingredient (API); Antiepileptic Drug API

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Pregabalin is a second- generation antiepileptic drug (AED) known with the proprietary brand name of Lyrica (Pfizer, Tadworth) in the UK and USA. Adjunctive therapy of focal seizures with and without secondary generalization. Pregabalin is a Anticonvulsant and antiepileptic drug used to treat epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its use for epilepsy is as an add-on therapy for partial seizures with or without secondary generalization in adults. Some off-label uses of pregabalin include, restless leg syndrome, migraine, social phobia, panic disorder, mania, bipolar disorder, and alcohol withdrawal. Pregabalin is a new antiepileptic drug, having a γ-amino butyric acid structure on its molecular structure, which has anticonvulsant effects, and is successfully developed by the company Pfizer for the treatment of peripheral neuropathic pain, or adjuvant treatment of partial seizures. In December 2008, the US Food and Drug Administration (FDA) approved pregabalin (trade name “Lyrica”) for the treatment of diabetic peripheral neuropathic pain (DPN) and postherpetic neuralgia (PHN)which are Both the most common neuropathic pains. Neuropathic pain is one of the most difficult chronic pain syndromes to treat, dull pain, burning, tingling as the main feature, there are a lot of incentives of neuralgia, diabetes, infections (such as herpes zoster), cancer and AIDS, etc. can cause neurological pain, in Europe about 3% of the population suffer from neuralgia torture.

Product detail pictures:

Related Product Guide:

Having a positive and progressive attitude to customer's fascination, our organization constantly improves our solution high-quality to fulfill the requirements of shoppers and further focuses on safety, reliability, environmental prerequisites, and innovation of High Quality for Acetaminophen - Pregabalin CAS 148553-50-8 Purity ≥99.0% (HPLC) Antiepileptic API – Ruifu , The product will supply to all over the world, such as: French, Jakarta, Mecca, We aim to become the modern enterprise with the commercial ideal of "Sincerity and confidence" and with the aim of "Offering customers the most sincere services and best quality products". We sincerely ask for your unchanged support and appreciate your kind advice and guidance.